Who should not take MK-677 (Ibutamoren)?
Documented caution flags for MK-677 (Ibutamoren) include active malignancy and pre-diabetic or insulin-resistant baseline. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for MK-677 (Ibutamoren) is limited.
Documented caution flags for MK-677 (Ibutamoren)
- Active malignancy
- Pre-diabetic or insulin-resistant baseline
- Pregnancy / nursing
Reported side effects to weigh
- Aggressive appetite stimulation
- Water retention / bloat
- Numb/tingling hands (carpal-tunnel-like)
- Insulin resistance creeping up over long use
References
- Effects of an oral ghrelin mimetic on body composition and clinical outcomes — Nass R et al., Ann Intern Med, 2008
- Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure — Svensson J et al., Journal of Clinical Endocrinology & Metabolism, 1998
- LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report — Cardaci TD et al., Experimental Physiology, 2022
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on MK-677 (Ibutamoren)
Full MK-677 (Ibutamoren) breakdownMK-677 (Ibutamoren) what it's used forMK-677 (Ibutamoren) side effectsMK-677 (Ibutamoren) how to take itMK-677 (Ibutamoren) mistakes to avoidMK-677 (Ibutamoren) half-lifeMK-677 (Ibutamoren) how long to workMK-677 (Ibutamoren) legal statusMK-677 (Ibutamoren) how it worksmk 677 vs ipamorelinhgh vs mk 677Ask the AI Coach
Last updated 2026-06-15.